Preclinical evaluation of a novel allosteric IL-1R inhibitor (rytvela) for the prevention of perinatal inflammation-induced fetal injury

  • Keelan, Jeff (Investigator 01)
  • Olson, Dave (Investigator 02)
  • Robertson, Sarah (Investigator 03)
  • Kemp, Matthew (Investigator 04)
  • Ellery, Stacey (Investigator 05)
  • Usuda, Haruo (Investigator 06)

Project Details

StatusFinished
Effective start/end date1/01/1831/12/22

Funding

  • NHMRC National Health and Medical Research Council : A$1,377,828.00